Visible Spectrophotometric Methods
Development for Quantification of Racecadotril in
Commercial Formulations
Koruprolu. Raghubabu1*, N. Mohan
Rao1, Buridi. Kalyana
Ramu2, C. Ramdas3
1Department of Engineering Chemistry, AU
College of Engineering (A), Andhra University,
Visakhapatnam-530003, AP (India)
2Department of Chemistry, Maharaja’s
College (Aided & Autonomous), Vizianagaram-535002, AP (India)
3M/S
Tychy Industries, R&D Division, Hyderabad (AP) India.
*Corresponding Author E-mail: drraghualways@yahoo.co.in,
kalyanaramu23566@gmail.com
ABSTRACT:
Three direct, simple and sensitive visible
spectrophotometric methods (M1,M2 and M3) are
described for the assay of Racecadotril in pure and
solid dosage forms. The method M1 is based on the formation of
colored molecular complex with sodium nitroprusside
in presence of acetaldehyde under alkaline conditions and exhibits λ max
at 560nm. The method M2 involves oxidative coupling of drug
with brucine in presence of sodium meta periodate and purple red colored species is formed and exhibits absorption maxima at
520nm. The method M3 is based on the formation of yellowish brown
colored species by the drug with Folin reagent and
exhibits absorption maxima at 450nm.Regression analysis of Beer-Lambert plots
showed good correlation in the concentration ranges (8.0-40) µg/ml for methods
M1, M2 and (20-60) µg/ml for method M3
respectively. The proposed methods are applied to commercial available
formulations and the results are statistically compared with those obtained by
the reported UV reference method (in methanol, λ max at 231nm)
and validated by recovery studies. The results are found satisfactory and
reproducible. These methods are applied successfully for the estimation of the Racecadotril in the presence of other ingredients that are
usually present in dosage forms.
KEYWORDS: Inner Molecular complex, Aromatic Nucleophillic substitution,
Oxidative coupling, Statistical analysis, Regression equation.
INTRODUCTION:
Racecadotril (RCT) 1(Figure1) is
an anti diarrheal drug and oral enkephalinase
inhibitor. Chemically it is (RS)-benzyl
N-[3-(acetylthio)-2-benzyl propanoyl]
glycinate with empirical formula of C21H23NO4S
and representing molecular weight of 385.476. It is a white crystalline powder
that is soluble in methanol, ethanol, acetonitrile
and dichloromethane. The drug is mainly used for the treatment of acute
diarrhea of bacterial and viral aetiology. The drug
acts by inhibition of enkephalinase, this produces an
increases in the levels of enkepalins that act in the
enterocyate, thus inhibits hyper secretion.
Figure 1: Chemical structure of Racecadotril
In
literature, several analytical methods such as HPLC2-6, HPLC tandem
MS7, HPTLC8, NMR9, spectrophotometry
and spectrofluorometry10, UV11-12 and visibleSpectrometric13-14
have been reported for the determination of RCT in bulk and formulations. Devala Rao et al reported three
visible spectrophotometric methods using FC reagent,
1,10-phenanthroline(PTL)-FeCl3and 2,2’-Bipyridine(BPN)-FeCl3
for the determination of the drug in formulations and the functional groups
present in the drug not fully exploited.
For routine quality control analysis, cost effective visible
spectrophotometric methods are required and preferred. Nevertheless, there
still exists a need for development of sensitive accurate and flexible visible
spectrophotometric methods for the determination of RCT in pharmaceutical
preparations. So the authors have made some attempts in this direction and
succeeded in developing three methods based on the reaction between the drug
and SNP-ACD 15-16(M1) or BCN-IO4-
reagent 17 (M2) or Folin
reagent 18 (M3) under specified experimental conditions.
These methods can be extended for the routine quality control analysis of
pharmaceutical products containing RCT.
MATERIALS AND METHODS:
Apparatus and
chemicals:
A Milton Roy UV/Visible spectrophotometer
model-1201 with 10mm matched quartz cells was used for all spectral
measurements. A Systronics digital pH meter mode-361
was used for pH measurements. All the chemicals used were of analytical grade.
Aqueous solutions of sodium nitro prusside (SNP, E. Merck, 1.0%, 3.35x10-2M),
acetaldehyde (10%), phosphate buffer of pH 8.0(prepared by mixing 30ml of
0.067M potassium hydrogen phosphate and 970ml of 0.067Mdisodium hydrogen
phosphate and pH adjusted to 8.0), aqueous solution of brucine
(Loba, 0.2%, 506.7x10-3M prepared by
dissolving 200mg of brucine initially in minimum
amount of 0.16M sulphuric acid and then made up to
100ml with distilled water), sodium metaperiodate (BDH,
0.2%, 9.35x10-3M prepared by dissolving 200mg of sodium metaperiodate in 100ml distilled water and standardized iodometrically) and sulphuric
acid (Qualigens,1.2M prepared by diluting 126ml of conc. H2SO4
to 100ml of distilled water initially, followed by diluting to 1000ml with
distilled water), Folin reagent (NQS) solution (Loba, 0.5%, 1.92x10-2M prepared by dissolving 500mg of NQS in 100 ml
of distilled water ) were prepared for methods M1 M2andM3
respectively.
Preparation of Standard stock solution:
The standard stock solution
(1mg/ml) of RCT was prepared by dissolving 100mg of RCT initially in 10 ml of
0.1MNaOH followed by dilution to 100ml with methanol for methods M1andM3.
The standard stock solution (1mg/ml) of RCT was prepared by dissolving 100mg of
RCT initially in 10 ml of methanol followed by dilution to 100ml with water for
method M2. The working standard solutions of RCT were obtained by
appropriately diluting the standard stock solution with the same solvent (M1and
M2- 200 µg/ml M3- 400 µg/ml). The prepared stock solution
was stored at 4⁰C protected from light. From
this stock solution, a series of standards were freshly prepared during the
analysis day.
Preparation of
Sample solution:
About 20 sachets/tablets were weighed to
get the average tablet weight and pulverized. The powder equivalent to 100mg of
RCT was weighed, dispersed in 25ml of Isopropyl alcohol, sonicated
for 15 minutes and filtered through Whatman filter paper No 41.The filtrate was
evaporated to dryness and the residue was dissolved as under standard solution
preparation.
Analytical
procedures:
Method M1:
Aliquots of standard RCT drug solution
[1.0-5.0ml, 200µg/ml] were delivered into a series of 25ml calibrated tubes
containing 15ml of buffer pH 8.0. Then 1.0ml each of SNP solution and
acetaldehyde were added successively and shaken for 2 minutes and kept aside
for 15 minutes at room temperature and made up to the mark with distilled
water. The purple colored species was obtained and it was stable for 1 hour. The absorbance of the colored species was
measured at 560nm against the reagent blank. The amount of drug was computed
from its calibration curve.
Method M2:
Aliquots of the standard RCT solution
[1.0-5.0ml, 200µg/ml] were placed in a series of 25ml standard flask. Then
3.0ml brucine, 1.5ml of NaIO4 solution and
2.0ml of sulphuric acid were added successively and
the volume was brought up to 10ml with distilled water and kept in boiling
water bath for 15min. for complete color development. The solution was cooled
to room temperature and the volume was made up to the mark with distilled
water. The absorbance was measured at 520nm against a reagent blank within the
stability period 60min. The calibration graph was constructed by plotting the
drug concentration versus absorbance. The amount of drug was computed from its
calibration graph.
Method M3:
To aliquots of the standard RCT solution
[1.0-3.0ml, 500µg/ml] 1.0ml of folin reagent
(1.092x10-2M), 5.0 ml of buffer pH 8.0 and 1.5ml of distilled water
were added and kept aside for 15 min for complete color development. Then the
volume was made up to 25 ml using distilled water and sonicated
for 1 min. The absorbance was measured at 450nm against a reagent blank within
the stability period 30min. The calibration graph was constructed by plotting
the drug concentration versus absorbance. The amount of drug was computed from
its calibration graph.
RESULTS AND
DISCUSSION:
In the present investigation, the presence
of aliphatic secondary amine of RCT permits the development of visible
spectrophotometric methods for its determination through inner molecular
complex formation with SNP-ACD (M1) or the oxidative coupling
reaction with BCN-IO4- reagent (M2) or the
aromatic nucleophillic substitution with folin reagent (M3).
Optimum operating conditions used in the
procedure were established adopting variation of one variable at a time (OVAT)
method. The effect of various parameters
such as time, volume and strength of reagents, the order of addition of
reagents, pH buffer solutions and solvent for final dilution of the colored
species were studied. The other oxidants such as Fe (III), Cr (IV), IO3-,
and S2O8-2 were tried in place of NaIO4
and found to be inferior incase of method M2. Distilled water was
found to be best solvent for final dilution. Other water miscible solvents like
methanol, ethanol, propan-2-ol and acetonitrile have
no additional advantage in increasing the intensity of the color in all three
methods. The optical characteristics
such as Beer’s law limit, Sandell‘s sensitivity,
molar absorptivity, percent relative standard
deviation, (calculated from the six measurements containing 3/4th of
the amount of the upper Beer’s law limits), Regression characteristics like
standard deviation of slope (Sb), standard
deviation of intercept (Sa), standard error of estimation (Se)
and % range of error (0.05 and 0.01 confidence limits) were calculated and the
results are summarized in Table-1.
Commercial formulations containing RCT were
successfully analyzed by the proposed methods. The values obtained by the
proposed and reference methods for formulations were compared statistically by
the t-and F-test and found not to differ significantly. As an additional
demonstration of accuracy, recovery experiments were performed by adding a
fixed amount of the drug to the pre analyzed formulations at three different
concentration levels. These results are summarized in Table-2.
Chemistry of
colored species:
Cullies and Waddington 15 found
that many secondary but not primary or tertiary amines react with sodium nitroprusside and acetaldehyde under mild alkaline
conditions. Wolfe and Swine hart16 have reported the formation of
[Fe(CN)5 H2O]3- in aqueous solution of sodium nitroprusside. The proposed method M1 exploits
structural features aliphatic secondary amine of the RCT molecule. The nature
of colored species formation with sodium nitroprusside-acetaldehyde
reagent is initial N-alkyl vinyl amine formation with acetaldehyde then
followed by formation of colored inner molecular complex with sodium nitroprusside has been assumed in the scheme. Based on the
analogy, the probable sequence of reactions is presented in scheme (Figure 2).
In method M2, the dimethoxy benzene nucleus of brucine
is attacked by IO4- with the formation of o-quinone (bruciquinone) which in
turn undergo nucleophillic attack on the most
electron-rich position of the coupler (secondary amino group of RCT) to give
1-monosubstituted bruciquinone
derivative(purple red colored species). In method M3, yellowish
brown colored species (N-alkyl amino napthaquinone)
was formed by replacement of the sulphonate group of
the napthaquinone sulphonic
acid by a secondary amino group of drug. The
formation of colored species with these reagents may be assigned through above
analogy as shown in Scheme (Figure 3and4).
Figure 2: Probable sequence of reaction for
method M1
Figure3: Probable scheme of reaction for
method M2
Figure 4: Probable Scheme of reaction for
method M3
CONCLUSION:
The proposed methods applicable for the
assay of drug, the advantage of wider range under Beer’s law limits, validated
as per ICH guide lines and possess reasonable precision, accuracy, and simple,
sensitive. The wavelength maximum (λmax)
and Sensitivity (€max) order of the proposed methods is M1>M2>M3.
These methods can be extended for the routine quality control analysis of RCT
in formulations.
Table 1: Optical
Characteristics, precision and accuracy of proposed methods.
Parameter |
Method M1 |
Method M2 |
Method M3 |
גmax (nm) |
560 |
520 |
450 |
Beer’s
law limit(µg/ml) |
8-40 |
8-40 |
20-60 |
Sandell’s sensitivity(µg/cm2/0.001 abs.
unit |
0.00372093 |
0.004102564 |
0.006530612 |
Molar absorptivity (Litre/mole/cm) |
103597.75 |
93960.75 |
59026.625 |
Regression
equation (Y)* |
|
|
|
Intercept
(a) |
0.004 |
0.001 |
-0.086 |
Slope(b) |
0.010 |
0.01 |
0.008 |
%RSD |
2.0 |
1.74 |
1.91 |
% Range
of errors(95% Confidence limits) 0.05
significance level 0.01
significance level |
|
|
|
2.1 |
1.8 |
2.0 |
|
3.3 |
2.8 |
3.10 |
*Y= a + b x; Where Y= absorbance, x=
concentration of RCT in µg/ml.
TABLE-2 ANALYSIS OF RCT BY PROPOSED AND
REFERENCE METHODS.
Method |
Formulation |
Labeled
Amount (mg) |
Found
by Proposed Methods |
Found
by Reference Method ± SD |
#%
Recovery by Proposed Method ± SD |
||
*Amount
found ± SD |
t |
f |
|||||
M1 |
Capsule |
10 |
9.77
± 0.10 |
2.17 |
1.61 |
9.86
± 0.13 |
97.73± 1.0 |
M2 |
Capsule
|
10 |
9.82
± 0.087 |
0.67 |
2.36 |
9.86
± 0.13 |
98.17
± 0.87 |
M3 |
Capsule |
10 |
9.9±
0.10 |
0.63 |
1.77 |
9.86
± 0.13 |
99.09±1.01 |
**Average ± Standard deviation of six determinations, the t-
and f-values refer to comparison of the proposed method with reference method.
(UV). Theoretical values at 95% confidence limits t =2.57 and F = 5.05.
#
Recovery of 10mg added to the pre-analyzed sample (average of three
determinations).
Reference method (reported UV method) using
methanol (λ max=231 nm).
ACKMOWLEDGEMENTS:
The authors thanks to R& D division
Tychy Industries, Hyderabad AP India for providing gift sample of the drug and
also thanks to University authorities for providing necessary facilities in
this work.
REFERENCES:
1 Budavari, S. Eds., In; The Merck Index, 13 th ed.,
Merck andCo Inc., Whitehouse Station, NJ., 2001,
1450.
2 Joseph, A; Kumar, CD; Prabu, SL and Shirwaikar, A et
al. (2007), “Determination of racecadotril by HPLC in
capsules”, Indian J Pharm Sci
, Vol. 69 (8), 819-821.
3 Anton, SA; Madhusudhana,
RI; Manavalan, R and Varaprasad,
K (2009), “Development and validation of a rapid RP-HPLC method for the
determination of Racecadotril in formulation”, Int J Chem Tech Res, Vol. 1 (4),
1090-1093.
4 Patel, YS; Sen,
AK; Seth, AK and Shah, B (2012), “Development and validation of new analytical
method for quantitative estimation of racecadotril as
an active pharmaceutical ingredient by RP-HPLC”, Pharm
Sci Moni, Vol. 3 (3),
2007-2017.
5 Deepti, J; Pawan, KB; Prabhat, KS and Surendra, KJ (2012), “RP-LC Analysis and Hydrolytic
Degradation Profile of Racecadotril”, Chromatographia, 68 (7), 641-647.
6 Xu, F; Xu, G and Yang, L (2008), “A rapid and validated HPLC
method to quantify racecadotril metabolite, thiorphan, in human plasma using solid-phase extraction”, J
Chromatogr B Analyt Technol Biomed Life Sci, Vol. 861
(1), 130-135.
7 Jia-Qing, Z;
Yong-Pin, Q; Yu, Q and Zheng, W et al.
(2008),”Quantitative Determination of Active Racecadotril
Metabolites in Human Plasma with High Performance Liquid Chromatography Tandem
Mass Spectrometry”, Chin J Anal Chem, Vol. 36, (1),
91-94.
8 Prabhu SL;
Joseph, A; Kumar, CD, Srinivasan KK, (2009), “HPTLC
method for analysis of racecadotril in the bulk
drug”, JPC-Journal of Planar Chromatography-Modern TLC, Vol. 22(4), 277-281.
9 Babu, JM;
Reddy, KM; Sudhakar, P and Vyas,
K (2006), “Structural studies of racecadotril and its
process impurities by NMR and mass spectroscopy”, Pharmazie,
Vol. 61 (12), 994-998.
10 Mohammed,
AM; Mohammed, GM; Mohammed, RE and Nouruddin, WA
(2011), “Spectrophotometric and Spectrofluorimetric
methods for determination of Racecadotril”, Pak J Pharm Sci, Vol. 24 (1), 19-23.
11 Aarti, Z; Pintoo, T; Seth, AK and Sharad. K
(2012), “Development of new analytical methods for quantitative estimation of racecadotril as an active pharmaceutical ingredient by UV
spectrophotometer”, Int J Pharm Sci Res, Vol. 3 (5), 1495-1497.
12 Sankar, M; Arulantony, S (2013),”New spectrophotometric method for
determination racecadotril in pharmaceutical dosage
forms”, Int. J Drug Res. Tech Vol. 3(3), 53-59.
13 Venumadhav, E; Amreen, N; Neeha, T and Bhargavi, P et al. (2010), “New Analytical Methods for the Estimation of Racecadotril In Bulk And Pharmaceutical Formulations”, Int Pharm Bio Sci,
Vol.1 (4), 348-351.
14 Narasimha Raju, BHCh, Delhiraj
N, Rao G. Devala (2011), “
Spectrophotometric methods for the determination of Racecadotril
in bulk and pharmaceutical dosage forms”, Vol. 4(11), 1739-1741.
15 Cullis CP. and B.J.Waddington.(1959)
Anal.Chem.Acta, 15, 158.
16 Wolfe SK and JH.Swinehart(1975)
, Inorg.Chem, 14, 1049.
17 D.L Massart,
B.G.M Vandegingtc, S.M Perming,
Y. Michotte and L. Kaufman, Chemometrics, A text book, Elsevier, Amsterdam, 283 (1988).
18 D.H Rosenblatt, P. Hlinka,
J. Epstein, Anal. Chem., 27, 1290
(1955).
Received on 30.12.2013 Modified on 01.03.2014
Accepted on 11.03.2014 ©A&V Publications All right reserved
Res. J.
Pharm. Dosage Form. and Tech. 6(3):July- Sept. 2014; Page 183-187